Diagnosis, treatment and monitoring systems
Clinical laboratories throughout the world depend on Beckman Coulter systems to deliver critical test results that are essential to the diagnosis, treatment and monitoring of patients. Scientists from leading universities and pharmaceutical companies use our state-of-the-art research solutions to generate quality data that will define tomorrow’s new biomedical tests and therapies. In fact, more than 200,000 of our systems currently operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care.
At Beckman Coulter we’re committed to leading the fight against HIV/AIDS. That’s why we’ve developed the CARE Systems, a ground-breaking family of integrated solutions specifically designed to bring high quality, affordable, easy-to-use CD4 monitoring tools to clinicians in a wide range of settings. From remote villages to centralized laboratories, our CARE Systems simplify and accelerate CD4 monitoring, and contribute to more affordable healthcare worldwide. Our FlowCARE System provides accurate percent and absolute CD4 values on patient specimens up to 5 days after collection. This simple but effective flow cytometry-based technique uses pre-optimized reagents to provide highly reliable results for all age groups. These unique capabilities allow a greater number of patients to be screened, from more remote locations, with test repeats dramatically reduced.
By providing complete solutions expressly designed to make CD4 monitoring more accessible, our CARE Systems deliver the critical missing link in the HIV/AIDS treatment continuum. With this comprehensive suite of innovative products, highly effective monitoring tools can now be taken directly to the point of care, radically accelerating time-to-treatment. Drawing from our combined history as a leading biomedical research and diagnostic company, we’ve marshaled resources from across the planet, and collaborated with leaders in healthcare to develop breakthrough CD4 monitoring solutions that contribute directly to the healing process. At Beckman Coulter, we’re bringing a world of CARE to a world in need.
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits and operating-type lease payments, represents approximately 78 percent of the company's 2008 annual revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.